SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001140361-20-024042
Filing Date
2020-10-29
Accepted
2020-10-29 07:04:22
Documents
70
Period of Report
2020-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q brhc10016325_10q.htm 10-Q 815982
2 EXHIBIT 31.1 brhc10016325_ex31-1.htm EX-31.1 9817
3 EXHIBIT 32.1 brhc10016325_ex32-1.htm EX-32.1 6740
  Complete submission text file 0001140361-20-024042.txt   5226672

Data Files

Seq Description Document Type Size
4 XBRL INSTANCE DOCUMENT rexn-20200930.xml EX-101.INS 1287974
5 XBRL TAXONOMY EXTENSION SCHEMA rexn-20200930.xsd EX-101.SCH 48398
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE rexn-20200930_cal.xml EX-101.CAL 43186
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE rexn-20200930_def.xml EX-101.DEF 146144
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE rexn-20200930_lab.xml EX-101.LAB 348187
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE rexn-20200930_pre.xml EX-101.PRE 296018
Mailing Address 15245 SHADY GROVE ROAD, SUITE 455 ROCKVILLE MD 20850
Business Address 15245 SHADY GROVE ROAD, SUITE 455 ROCKVILLE MD 20850 2402685300
REXAHN PHARMACEUTICALS, INC. (Filer) CIK: 0001228627 (see all company filings)

IRS No.: 113516358 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-34079 | Film No.: 201270450
SIC: 2834 Pharmaceutical Preparations